Please disable your ad-blocker and refresh. The simple moving average for the period of the last 20 days is -0.08% for BIOC stocks with the simple moving average of 35.08% for the last 200 days.Many brokerage firms have already submitted their reports for BIOC stocks, with Chardan Capital Markets repeating the rating for BIOC shares by setting it to “Buy”. NASDAQ 0.00%.
Export data to Excel for your own analysis. The company’s... Biocept Inc (BIOC) stock is higher by 6432.26% over the past week and gets a Neutral rating from InvestorsObserver's Sentiment Indicator. The company’s stock... Want to see which stocks are moving? The RSI (14) is pointing at 29.34 while the volatility over the past week is 11.55% and jumps to 11.67% over the past one month. Anaplan, Inc. (NYSE:PLAN) went up by 2.32% from its latest closing price compared to the recent 1-year high of $63.71. These price ends are 352.49% and +4560.63% off the current price level respectively, although investors could be excited at the prospect of a +2456.56% if the BIOC share price touches on the median price of $113.Let’s briefly compare Biocept, (BIOC) stock to its peers.
Stryker Corporation (NYSE:SYK) went up by 2.66% from its latest closing price compared to the recent 1-year high of $226.30. The company’s stock... Press Releases. The... Analysts’ Opinion on Biocept, Inc. (NASDAQ:BIOC… Biocept, Inc. (NASDAQ:BIOC) traded at $4.42 at last check on Tuesday, Sep 08, making a downturn move of -16.89% on its previous day’s price. Datadog, Inc. (NASDAQ:DDOG) went up by 2.50% from its latest closing price compared to the recent 1-year high of $98.99. Log into your account. The company’s stock... Anaplan, Inc. (NYSE:PLAN) went up by 2.32% from its latest closing price compared to the recent 1-year high of $63.71. Rooms Trade App. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages.
Biocept, Inc. (NASDAQ: BIOC) The 36 Months beta value for BIOC stocks is at 0.73, while 2 of the analysts out of 2 who provided ratings for Biocept, Inc. stocks as a “buy” while 0 as overweight, 0 rated it as hold and 0 as sell. Post-split trading will commence at the open on Tuesday, September 8....SAN DIEGO, Sept. 4, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve patient outcomes, announces that, as a result of the Company's one-for-ten…Biocept ([[BIOC]] +4.5%) is up, albeit on below-average volume, in reaction to its announcement that it has processed more than 20K COVID-19 specimens in its molecular lab, most reported within 48 hours of receipt.It has distributed 46K PCR specimen collection kits thus far and has 34K more available for distribution.CEO...Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Join Today!
The simple moving average for the period of the last 20 days is -14.87% for BIOC stocks with the simple moving average of 50.57% for the last 200 days. The company’s stock price... Waitr Holdings Inc. (NASDAQ:WTRH) went up by 2.53% from its latest closing price compared to the recent 1-year high of $5.85. The company’s stock price... The rating they have provided for BIOC stocks is “Buy” according to the report published on June 2, 2017.ROTH Capital gave “Buy” rating to BIOC stocks, setting the target price at $1.20 in the report published on June 6, 2016.After a stumble in the market that brought BIOC to its low price for the period of the last 52 weeks, Biocept, Inc. was unable to take a rebound, for now settling with -42.91% of loss for the given period.The stock volatility was left at 17.21%, however, within the period of a single month, the volatility rate increased by 12.16%, while the shares surge at the distance of +21.62% for the moving average in the last 20 days. The... Just enter your email address below.Below are the latest news stories about Biocept Inc that investors may wish to consider to help them evaluate BIOC as an investment opportunity.Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostics designed to provide physicians with clinically actionable information to improve the patient outcomes, announces that President and CEO Michael Nall will present at the H.C. Wainwright 22nd Annual Global Investment Conference on Monday, September 14, 2020 at 3:30 p.m. Eastern time (12:30 p.m. Pacific time).Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve patient outcomes, announces it has entered into an agreement with Health Net Federal Services LLC to be an in-network provider for its Target Selector™ liquid biopsy oncology platform for the TRICARE West (TriWest) region network. Maxim Integrated Products, Inc. (NASDAQ:MXIM) went up by 2.45% from its latest closing price compared to the recent 1-year high of $73.52. Learn everything you need to know about successful options trading with this three-part video course.Looking for new stock ideas? Total capital return value is set at -250.49, while invested capital returns managed to touch -310.32. Old Dominion Freight Line, Inc. (NASDAQ:ODFL) went up by 2.45% from its latest closing price compared to the recent 1-year high of $207.43. Please log in to your account or sign up in order to add this asset to your watchlist. Biocept Inc. [BIOC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.17. Intercontinental Exchange, Inc. (NYSE:ICE) went up by 2.42% from its latest closing price compared to the recent 1-year high of $106.99. BIOC 0.53 0.05 (8.88%) … In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -2.78% and -2.25%, respectively, in early deals. Biocept. Biocept, Inc. (NASDAQ:BIOC) traded at $4.42 at last check on Tuesday, Sep 08, making a downturn move of -16.89% on its previous day’s price.Looking at the stock we see that its previous close was $5.32 and the beta (5Y monthly) reads 0.72. The net margin for Biocept, Inc. stands at -454.69. © 2020 Market data provided is at least 10-minutes delayed and hosted by Deere & Company (NYSE:DE) went up by 2.51% from its latest closing price compared to the recent 1-year high of $219.71.